Related Experiment Video
Updated: May 21, 2026

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
Gamabufotalin Suppresses Colorectal Cancer Growth via Oxidative Stress-Induced Apoptosis and DNA Synthesis Inhibition
Hui Nie1, Anfang Cui2, Zhicheng Sun3
1School of Pharmacy, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, China.
Background:
Colorectal cancer (CRC) continues to be a major cause of cancer-related mortality worldwide, creating an urgent need to develop novel therapeutic agents that are both highly effective and minimally toxic. Gamabufotalin (GA), a bioactive bufadienolide compound, has shown promising antitumor potential, including against CRC; however, its precise mechanisms of action in CRC remain incompletely understood.
Objectives:
The aim of this study was to investigate the therapeutic effect of GA on CRC and explore the underlying molecular mechanisms.
Methods:
A combination of in vitro and in vivo approaches was employed, including cell viability assays, colony formation, EdU incorporation, cell cycle and apoptosis analyses by flow cytometry, ROS and mitochondrial membrane potential detection, as well as integrated transcriptomic and proteomic profiling. The in vivo antitumor efficacy was further validated in a nude mouse xenograft model.
Results:
Gamabufotalin exhibited potent, dose-dependent anti-CRC activity in vitro (IC50: 24-30 nM) with high selectivity over normal cells. It triggered mitochondrial apoptosis via ROS generation and arrested the cell cycle, suppressing DNA synthesis. Integrated omics revealed TP53I3/PIG3 upregulation and RFC3/NUCKS1 downregulation as key mechanisms. Critically, these effects converged to suppress tumor growth in vivo without systemic toxicity.
Conclusions:
Gamabufotalin selectively and potently inhibits CRC through dual mechanisms: Inducing ROS-mediated apoptosis and suppressing proliferation. With a favorable therapeutic index and defined molecular targets, GA represents a promising candidate for CRC therapy.
Insights
Gamabufotalin (GA) shows potent anti-colorectal cancer (CRC) activity by inducing cell death and halting proliferation. This compound effectively suppresses tumor growth in vivo with minimal toxicity, offering a promising new therapeutic avenue.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Colorectal cancer (CRC) remains a leading cause of cancer mortality globally.
- There is a critical need for novel, effective, and less toxic therapeutic agents for CRC.
- Gamabufotalin (GA), a bufadienolide, exhibits potential antitumor activity, but its mechanisms in CRC require elucidation.
Purpose of the Study:
- To investigate the therapeutic efficacy of Gamabufotalin (GA) against colorectal cancer (CRC).
- To explore the underlying molecular mechanisms of GA's action in CRC.
Main Methods:
- Utilized in vitro assays (cell viability, colony formation, EdU, cell cycle, apoptosis, ROS, mitochondrial potential) and in vivo xenograft models.
- Integrated transcriptomic and proteomic profiling to identify molecular targets.
- Validated GA's efficacy and toxicity in a nude mouse model.
Main Results:
- GA demonstrated potent, dose-dependent anti-CRC activity in vitro (IC50: 24-30 nM) with high selectivity.
- GA induced mitochondrial apoptosis via reactive oxygen species (ROS) generation and cell cycle arrest, inhibiting DNA synthesis.
- Omics analysis revealed TP53I3/PIG3 upregulation and RFC3/NUCKS1 downregulation as key mechanisms.
- GA suppressed tumor growth in vivo without observable systemic toxicity.
Conclusions:
- Gamabufotalin (GA) selectively and potently inhibits CRC via ROS-mediated apoptosis and proliferation suppression.
- GA possesses a favorable therapeutic index and defined molecular targets.
- GA presents a promising therapeutic candidate for colorectal cancer treatment.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Drugs for Treatment of Ulcerative Colitis in IBD
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
